A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

✍ Scribed by Jens Overgaard; Hanne Sand Hansen; Marie Overgaard; Lars Bastholt; Anne Berthelsen; Lena Specht; Birgit Lindeløv; Karsten Jørgensen

• Book ID: 119521958
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 185 KB
• Volume: 46
• Category: Article
• ISSN: 0167-8140
• DOI: 10.1016/s0167-8140(97)00220-x